PowerLattice vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

PowerLattice

EmergingArtificial Intelligence

Power Delivery Chiplet for AI Accelerators

Raised $25M Series A (Nov 2025) led by Playground Global and Celesta Capital. Pat Gelsinger (ex-Intel CEO) on board. TSMC production underway. Cuts AI compute power draw by 50%+.

About

PowerLattice is developing a power delivery chiplet that installs alongside existing AI accelerators to cut compute power consumption by 50%+ — addressing the AI data center power wall that is constraining the expansion of hyperscale AI infrastructure. The company raised $25 million in Series A financing in November 2025 led by Playground Global and Celesta Capital, with Pat Gelsinger (former Intel CEO who oversaw Intel's semiconductor manufacturing revival) joining the board. TSMC is producing PowerLattice's chiplet with customer testing expected in the first half of 2026.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.